Genedrive (GB:GDR) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Genedrive PLC has released its 2024 Annual Report and announced the upcoming Annual General Meeting on December 30, 2024. The company, a leader in pharmacogenetic testing, continues to innovate with its Genedrive® MT-RNR1 and CYP2C19 ID Kits, enhancing personalized medicine and improving patient outcomes in emergency care. The company is focused on growth through market expansion and strategic acquisitions.
For further insights into GB:GDR stock, check out TipRanks’ Stock Analysis page.
